Questions & Answers
Meningococcal - The Vaccine
Back to Parent Q&A Category Back to All Meningococcal Q&A Back to All Q&A Back to Meningococcal

Administration

Questions
Answers
  1. How is this vaccine given?
    Menomune is injected subcutaneously (under the skin) as a single 0.5mL dose. Booster doses are recommended after 3 to 5 years for those traveling to endemic areas, people without spleens and certain immune-compromised individuals. Menactra is injected intramuscularly as a single 0.5ml dose. The need for a booster dose has not yet been determined.

  2. How many doses of meningococcal vaccine are needed?
    Usually, only one dose is needed. Sometimes an additional dose is recommended for people who remain at high risk (ask your provider). With Menomune, revaccination after three to five years may be needed for people who continue to be at high risk of infection.

    While not generally recommended, MPSV4 may be recommended for children 3 months to 2 years old under special circumstances. These children should receive 2 doses, 3 months apart.

  3. Can the vaccine cause meningococcal disease?
    No. It does not contain live bacteria.

  4. Should college students be vaccinated against meningococcal disease?
    College freshmen who live in, or plan to live in, dormitories should consider receiving the vaccine. Some schools now require incoming freshmen to be immunized. The vaccine may be available from the college health service.

  5. How long does the meningococcal vaccine last?
    With Menomune, revaccination after three to five years may be needed for people who continue to be at high risk of infection.